CD274 and non-small cell lung carcinoma: All may interfere with our endeavor to identify the relationship between PD-L1 expression and the efficacy of anti-PD-1/PD-L1 antibodies, for blueprint study showed interchangeability of 22C3 and other antibodies but lower sensitivity of SP142 in NSCLC TPS IHC assay (34).